Interim Financial Statements of Icelandair Group hf. 30 June 2024
8
Amounts are in USD thousands
Consolidated Statement of Cash Flows
for the six months ended 30 June 2024
Notes 2024 2023 2024 2023
Q2 Q2 YTD YTD
Cash flows to operating activities
622 13,656 58,795 )( 35,476 )(
Adjustments for:
9 37,261 34,746 70,822 64,285
12,923 7,104 23,132 12,329
10 2,139 7,255 5,445 10,197
42 )( 372 )( 73 )( 493 )(
0 1,381
0 1,381
646 361 )( 1,103 174
98 )( 1,685 13,336 )( 14,285 )(
53,451 62,332 28,298 35,350
Chan
es in:
820 630 )( 306 993 )(
6,165 49,137 38,279 )( 26,714 )(
42,226 29,580 69,060 62,445
7,484 3,237 )( 202,810 229,762
56,695 74,850 233,897 264,500
10,176 1,785 14,160 4,439
10,079
9,966
19,010
20,874
Net cash from operatin
activities 110,243 129,001 257,345 283,415
Cash flows to investing activities:
30,881 )( 38,356 )( 59,792 )( 78,722 )(
55 391 101 686
1,229 )( 350 )( 3,870 )( 9,022 )(
148 )( 91 )( 670 )( 175 )(
212 2,895 212 2,895
1,727 4,472 )( 2,202 8,261 )(
72,020 )( 11,469 )( 51,004 )( 26,678 )(
Net cash used in investing activities 102,284 )( 51,452 )( 112,821 )( 119,277 )(
Cash flows to financing activities:
0 0 0 63,461
11,307 )( 14,292 )( 24,362 )( 28,848 )(
14,793 )( 11,368 )( 28,240 )( 22,977 )(
Net cash used in financin
activities 26,100
25,660
52,602
11,636
Change in cash and cash equivalents
..................................................
18,141
51,889
91,922
175,774
Effect of exchange rate fluctuations on cash held
..............................
3 )( 22 275 )( 368
Cash and cash equivalents at beginning of the period
......................
309,305 348,483 199,514 224,252
Cash and cash equivalents at period end
............................................
291,161 400,394 291,161 400,394
122,013 68,837 122,013 68,837
Cash, cash equivalents and marketable securities at period end
..
413,174 469,231 413,174 469,231
Investment and financing without cash flow effect, see note 17.
The notes on pages 9 to 15 are an integral part of these Interim Consolidated Financial Statements.
Inventories ..........................................................................................
Deferred cost, change .............................................................................
Deferred income .................................................................................
Trade and other receivables ...............................................................
Depreciation and amortization ............................................................
Expensed deferred cost ......................................................................
Net finance cost ..................................................................................
Gain on sale of operating assets ........................................................
Share in loss (profit) of associates .....................................................
Income tax ..........................................................................................
Interest received .................................................................................
Profit (loss) for the period .......................................................................
Repayment of loans and borrowings .......................................................
Proceeds from loans and borrowings ......................................................
Marketable securities, change .................................................................
Acquisition of operating assets ................................................................
Proceeds from sale of operating assets ..................................................
Acquisition of intangible assets ................................................................
Gain on sale of subsidiary ..................................................................
Trade and other payables ...................................................................
Interest paid ........................................................................................
Repayment of lease liabilites ...................................................................
Non-current receivables, change .............................................................
Proceeds from sale of associates ............................................................
Marketable securities ...............................................................................